// App-Quantinova.ai

: Joint space width inclusion criteria can reduce knee osteoarthritis trial heterogeneity: post-hoc data from a phase 2 trial of wnt pathway inhibitor, SM04690

Researchers

Presenter

  • P. Conaghan

Principal Investigators

  • J. Tambiah

  • C.J. Swearingen

  • S. Kennedy

  • M. Bowes

  • A. Brett

  • C. Lattermann

Medical Centers

  • University of Leeds, Leeds, United Kingdom

  • Samumed, San Diego, CA

  • Imorphics, Manchester, United Kingdom

  • Univ. of Kentucky, Lexington, KY, USA

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Knee osteoarthritis

Biomarkers

  • N/A

Drug/Treatment

  • SM04690

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved